Medipost Co., Ltd
USPTO PatentsView assignee record - 12 granted patents across 4 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Medipost ranks #22,964 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 4 technology areas.
- #22,964
- of 49,997 US assignees by volume
- 10th percentile
- by Innovation Score (22.5/100)
- 7.3
- avg claims per patent
- -90%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R22964 · Foreign Corporation #22,964 · 12 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 12 grants
- MID-PACK #22,964/49,997
- PHOTO-FINISH Maxlinear Asia…
- CPC-NARROW A61K · 4 areas
- INNOV-THIN 22.5/100
- CLAIMS-SPARSE 7.3 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -90% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Maxlinear Asia Singapore Private Limited (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Medipost’s 22.5 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Medipost
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Medipost · this assignee 23
Medipost · this assignee
23 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Medipost's Innovation Score is 22.5/100 (10th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Medipost?
Each dot is one of Medipost’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Medipost’s own 7.3 claims/patent is at or below the 18.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Medipost's grants concentrate
Medipost Co., Ltd is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2016 (4 grants) versus a trough of 1 in 2015. By volume, Medipost sits between Maxlinear Asia Singapore Private Limited and Memsen Electronics Inc..
Medipost's three-year grant acceleration
Medipost Co., Ltd shows 1 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Medipost's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Maxlinear Asia Si…
Maxlinear Asia Singapore Private Limited
12 patents
- Media IP
Media IP, Inc.
12 patents
- Medical Microinst…
Medical Microinstruments, Inc.
12 patents
- Medigene Immunoth…
Medigene Immunotherapies GMBH
12 patents
- Meiji University
Meiji University
12 patents
- Meissner Filtrati…
Meissner Filtration Products, Inc.
12 patents
- Melitta Single Po…
Melitta Single Portions GMBH & Co. KG
12 patents
- Memsen
Memsen Electronics Inc.
12 patents
- Medipost ◀
Medipost Co., Ltd
12 patents
What this shows Medipost holds 12 patents at rank #22,936, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Medipost
By rank, the assignees closest to #22,936 in granted patent volume.
- Maxlinear Asia Singapore Private Limited #22,932 · 12 patents
- Media IP, Inc. #22,933 · 12 patents
- Medical Microinstruments, Inc. #22,934 · 12 patents
- Medigene Immunotherapies GMBH #22,935 · 12 patents
- Meiji University #22,937 · 12 patents
- Meissner Filtration Products, Inc. #22,938 · 12 patents
- Melitta Single Portions GMBH & Co. KG #22,939 · 12 patents
- Memsen Electronics Inc. #22,940 · 12 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in Medipost's primary technology class.
- The Regents of the University of California 1,779 in class
- L'Oreal 1,250 in class
- Novartis AG 988 in class
- The Procter & Gamble Company 985 in class
- The Board of Regents of the University of Texas System 950 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 813 in class
- The Trustees of the University of Pennsylvania 768 in class
- Merck Sharp & Dohme LLC 760 in class
Medipost's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
23 10th percentile higher than 10% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 8.3% |
| 2016 | 4 | 33.3% |
| 2017 | 1 | 8.3% |
| 2018 | 1 | 8.3% |
| 2019 | 3 | 25.0% |
| 2022 | 1 | 8.3% |
| 2025partial year | 1 | 8.3% |
Which technologies does Medipost Co., Ltd patent most?
Top 4 of 4 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Medipost Co., Ltd's patent record in context - here's where to go next.
- Medipost Co., Ltd's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
- Ranked #22,964 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Medipost Co., Ltd against Maxlinear Asia Singapore Private Limited, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 22.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.